| The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... cell 155 (2), 462-477, 2013 | 5377 | 2013 |
| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 5043 | 2018 |
| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 3097 | 2018 |
| Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma HS Friedman, MD Prados, PY Wen, T Mikkelsen, D Schiff, LE Abrey, ... Journal of clinical oncology 27 (28), 4733-4740, 2009 | 3063 | 2009 |
| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2840 | 2018 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2437 | 2018 |
| Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 2288 | 2018 |
| Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors JE Eckel-Passow, DH Lachance, AM Molinaro, KM Walsh, PA Decker, ... New England Journal of Medicine 372 (26), 2499-2508, 2015 | 2173 | 2015 |
| Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018 | 1861 | 2018 |
| Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors IK Mellinghoff, MY Wang, I Vivanco, DA Haas-Kogan, S Zhu, EQ Dia, ... New England Journal of Medicine 353 (19), 2012-2024, 2005 | 1754 | 2005 |
| Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas JS Smith, EF Chang, KR Lamborn, SM Chang, MD Prados, S Cha, ... Journal of clinical oncology 26 (8), 1338-1345, 2008 | 1463 | 2008 |
| A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse WKA Yung, RE Albright, J Olson, R Fredericks, K Fink, MD Prados, ... British journal of cancer 83 (5), 588-593, 2000 | 1221 | 2000 |
| Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials ET Wong, KR Hess, MJ Gleason, KA Jaeckle, AP Kyritsis, MD Prados, ... Journal of Clinical Oncology 17 (8), 2572-2572, 1999 | 1094 | 1999 |
| Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ... Cell reports 23 (1), 239-254. e6, 2018 | 1019 | 2018 |
| Genomic and functional approaches to understanding cancer aneuploidy AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ... Cancer cell 33 (4), 676-689. e3, 2018 | 989 | 2018 |
| Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ... Cell reports 23 (1), 181-193. e7, 2018 | 958 | 2018 |
| Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse WKA Yung, MD Prados, R Yaya-Tur, SS Rosenfeld, M Brada, ... Journal of Clinical Oncology 17 (9), 2762-2762, 1999 | 939 | 1999 |
| The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018 | 926 | 2018 |
| Comprehensive analysis of alternative splicing across tumors from 8,705 patients A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ... Cancer cell 34 (2), 211-224. e6, 2018 | 844 | 2018 |
| Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018 | 796 | 2018 |
